-transparent.png){kind=logo}
The effects of thymidine and uridine on the phosphorylation of 3'-azido-3'-deoxythymidine (AZT) were studied in various human mononuclear cell preparations. Thymidine suppressed [3H]AZT phosphorylation in the same concentration range (20 to 100 microM) in which it antagonizes the anti-human immunodeficiency virus activity of AZT. Uridine, in turn, had no influence on AZT phosphorylation, just as it has no effect on the anti-human immunodeficiency virus activity of AZT. These findings are consistent with a close relationship between the inhibition of AZT phosphorylation and the influence of physiological nucleosides on the antiviral activity of AZT.
Related Publications
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
January 1996,
Chemotherapy,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
January 1989,
Advances in experimental medicine and biology,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
July 1988,
Biochemical and biophysical research communications,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
August 2004,
Drug metabolism and disposition: the biological fate of chemicals,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
December 1990,
Biochemical pharmacology,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
February 1992,
Molecular pharmacology,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
January 1993,
Oncology research,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
August 1990,
Molecular pharmacology,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
July 2006,
Biochemical pharmacology,
J Szebeni, and
S S Patel, and
K Hung, and
L M Wahl, and
J N Weinstein
October 1994,
British journal of clinical pharmacology,
